1. Home
  2. BLIN vs ADXN Comparison

BLIN vs ADXN Comparison

Compare BLIN & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$0.87

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Logo Addex Therapeutics Ltd

ADXN

Addex Therapeutics Ltd

N/A

Current Price

$6.89

Market Cap

8.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLIN
ADXN
Founded
2000
2002
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
8.0M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
BLIN
ADXN
Price
$0.87
$6.89
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.62
N/A
AVG Volume (30 Days)
17.1K
5.4K
Earning Date
05-14-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,568,000.00
N/A
Revenue This Year
$22.67
$86.57
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$5.41
52 Week High
$2.22
$12.05

Technical Indicators

Market Signals
Indicator
BLIN
ADXN
Relative Strength Index (RSI) 52.88 52.54
Support Level $0.79 $5.49
Resistance Level $0.93 $7.15
Average True Range (ATR) 0.05 0.57
MACD 0.00 0.10
Stochastic Oscillator 64.52 67.58

Price Performance

Historical Comparison
BLIN
ADXN

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: